Middle East & Africa Pharmaceutical Excipients Market

The Middle East & Africa pharmaceutical excipients market is expected to grow from US$ 249.21 million in 2022 to US$ 336.74 million by 2028. It is estimated to register a CAGR of 5.1% from 2022 to 2028.

Rising Demand and Emphasis on Co-processed Excipients is fueling the growth of Middle East & Africa Pharmaceutical Excipients Market

Formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain APIs to be manufactured adequately. These scientists focus on the production of co-processed and multifunctional excipients with enhanced performance. Co-processed excipients are a mixture of two or more existing excipients at the sub-particle level, offering substantial benefits of the incorporated excipients and minimizing their drawbacks. These multipurpose excipients have dramatically reduced the number of incorporating excipients in the tablet. The co-processed excipients are used to improve the drug's flow, disintegration, lubrication, and compressibility. The excipients also simplify the formulation process and make it cost-effective. The companies are focusing on developing co-processed excipients for drug formulations. For instance, in July 2021, DFE Pharma launched a co-processed excipient, Pharmacel sMCC 90, silicified microcrystalline cellulose (MCC). It has been developed as the synergistic solution for challenging oral solid dosage formulations. A co-processed excipient is a promising tool in the production of pharmaceutical products. There is also enough space for the production of new co-processed excipients to satisfy the demand of the pharmaceutical industries, which is expected to act as an opportunity for the growth of the of Middle East & Africa pharmaceutical excipients market during the forecast period.

Market Overview

The Pharmaceutical Excipients market in the Middle East & Africa is further segmented into the UAE, Saudi Arabia, and South Africa. The market is expected to grow due to the huge population base, increase in the prevalence of chronic diseases, and growing research studies across the region. Moreover, surge in the generics and ever-expanding pharmaceutical industry. Saudi Arabia is one of the fastest-growing countries in the Middle East & Africa, whose growth is driven by a huge population base and increasing prevalence of chronic diseases. For instance, according to World Health Organization (WHO), chronic and non-communicable diseases account for more fatalities in Saudi Arabia. It is estimated that by 2030, more than 23 million people will die annually from CVD. Heart disease, stroke, and diabetes alone will reduce gross domestic product from between 1% to 5% in most of the low- and middle-income countries. The affordability and availability of essential medicines for managing common cardiovascular diseases is a key challenge for Saudi Arabia. The prevalence of chronic diseases demands a huge supply of pharmaceutical drugs, and drug manufacturing needs quality excipients. This growing demand for pharmaceutical excipients is boosting the market growth. The demand for cheaper quality excipients from emerging economies such as Saudi Arabia is growing. Hence, the need for functionality excipients is growing across the country, driving the market in the country.

Middle East & Africa Pharmaceutical Excipients Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Pharmaceutical Excipients Strategic Insights

Strategic insights for the Middle East & Africa Pharmaceutical Excipients provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Pharmaceutical Excipients Report Scope

Middle East & Africa Pharmaceutical Excipients Regional Insights

The geographic scope of the Middle East & Africa Pharmaceutical Excipients refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Pharmaceutical Excipients Market Segmentation

The Middle East & Africa pharmaceutical excipients market is segmented into type, clinical indication, functionality, application, end user, and country. Based on type, the of Middle East & Africa pharmaceutical excipients market is segmented into bioresorbable polymers & lipids & liposome-based formulation, oleochemicals, sugars, cellulose, starches, petrochemicals, plant protein & polyols & cyclodextrins, inorganic chemicals, and others. The inorganic chemicals segment registered the largest market share in 2022.

Based on clinical indication, the Middle East & Africa pharmaceutical excipients market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others. The cancer segment registered the largest market share in 2022.

Based on functionality, the Middle East & Africa pharmaceutical excipients market is segmented into coloring agent & coating agents, sweetener & flavoring agents, suspending & viscosity agents, preservative & controlled-release, antioxidant & oil, tablet filler & diluents, binders & compression aids & granulating agents, emulsifiers, and others. The tablet filler and diluents segment registered the largest market share in 2022.

Based on application, the Middle East & Africa pharmaceutical excipients market is segmented into parenteral, orals formulations & tablets, capsules, liquid & injectable, physicochemical excipient container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. The orals formulations & tablets segment registered the largest market share in 2022.

Based on end user, the Middle East & Africa pharmaceutical excipients market is segmented into biopharma industries, pharma industries, animal health, and others. The pharma industries segment registered the largest market share in 2022.

Based on country, the of Middle East & Africa pharmaceutical excipients market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

Archer-Daniels-Midland Co, AshLand Inc, Avantor Inc, BASF SE, Evonik Industries AG, JRS PHARMA GmbH & Co. KG, MEGGLE GmbH & Co KG, Roquette Freres SA, The Dow Chemical Co, and The Lubrizol Corp are among the leading companies operating in the of Middle East & Africa pharmaceutical excipients market.